Zoetis Inc.

NYSE:ZTS Stock Report

Market Cap: US$70.9b

Zoetis Future Growth

Future criteria checks 2/6

Zoetis is forecast to grow earnings and revenue by 7.4% and 5.2% per annum respectively. EPS is expected to grow by 8.4% per annum. Return on equity is forecast to be 50.6% in 3 years.

Key information

7.4%

Earnings growth rate

8.4%

EPS growth rate

Pharmaceuticals earnings growth14.4%
Revenue growth rate5.2%
Future return on equity50.6%
Analyst coverage

Good

Last updated09 May 2025

Recent future growth updates

Zoetis Inc. (NYSE:ZTS) Yearly Results: Here's What Analysts Are Forecasting For This Year

Feb 15
Zoetis Inc. (NYSE:ZTS) Yearly Results: Here's What Analysts Are Forecasting For This Year

Recent updates

Zoetis Inc.'s (NYSE:ZTS) Intrinsic Value Is Potentially 41% Above Its Share Price

Apr 30
Zoetis Inc.'s (NYSE:ZTS) Intrinsic Value Is Potentially 41% Above Its Share Price

Zoetis Inc. (NYSE:ZTS) Investors Are Less Pessimistic Than Expected

Apr 02
Zoetis Inc. (NYSE:ZTS) Investors Are Less Pessimistic Than Expected

Zoetis: Lots Of Growth Opportunities For This High-Quality Compounder

Mar 25

Zoetis: Focusing On The High Margin Segments

Mar 13

Zoetis Inc. (NYSE:ZTS) Yearly Results: Here's What Analysts Are Forecasting For This Year

Feb 15
Zoetis Inc. (NYSE:ZTS) Yearly Results: Here's What Analysts Are Forecasting For This Year

Zoetis: In-Line Q4 Earnings And Weak Guidance Present A Buying Opportunity

Feb 13

Is Zoetis (NYSE:ZTS) Using Too Much Debt?

Jan 31
Is Zoetis (NYSE:ZTS) Using Too Much Debt?

Are Investors Undervaluing Zoetis Inc. (NYSE:ZTS) By 33%?

Jan 10
Are Investors Undervaluing Zoetis Inc. (NYSE:ZTS) By 33%?

The Wall Street Journal Vs. Zoetis

Dec 26

Zoetis: Are Competition And Price Increases A Cause For Concern?

Dec 06

Zoetis: Healing Paws, Growing Profits

Nov 29

Zoetis: This Beautifully Boring, Slow-Growing Compounder Is A Buy

Nov 18

Zoetis (NYSE:ZTS) Has A Pretty Healthy Balance Sheet

Oct 26
Zoetis (NYSE:ZTS) Has A Pretty Healthy Balance Sheet

Zoetis: A Solid Choice For The Young Dividend Growth Investor

Oct 09

Do Zoetis' (NYSE:ZTS) Earnings Warrant Your Attention?

Oct 08
Do Zoetis' (NYSE:ZTS) Earnings Warrant Your Attention?

Zoetis: Investing In Pet Health And Portfolio Wealth

Sep 26

Are Investors Undervaluing Zoetis Inc. (NYSE:ZTS) By 23%?

Sep 20
Are Investors Undervaluing Zoetis Inc. (NYSE:ZTS) By 23%?

There's Reason For Concern Over Zoetis Inc.'s (NYSE:ZTS) Price

Aug 30
There's Reason For Concern Over Zoetis Inc.'s (NYSE:ZTS) Price

Zoetis: Librela Sales Should Peak 200-300% Above Management's $1B Target

Aug 13

Zoetis Q2 Earnings: Harvesting From DTC (Rating Upgrade)

Aug 07

Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?

Jul 16
Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?

Zoetis: A High-Quality Business And Fast Dividend Growth At A Reasonable Price

Jul 03

Zoetis: Don't Fret Excessively Over The Animal Healthcare Leader

Jun 11

A Look At The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Jun 10
A Look At The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Zoetis (NYSE:ZTS) Ticks All The Boxes When It Comes To Earnings Growth

May 23
Zoetis (NYSE:ZTS) Ticks All The Boxes When It Comes To Earnings Growth

Zoetis: Why The Focus On Companion Animal Segment Will Pay Off

May 22

Zoetis: Long-Term Buy Despite Safety Concerns

May 03

Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment

Apr 15

Zoetis: My Favorite Healthcare Stock Right Now

Mar 21

Zoetis: Buy This High-Quality Dividend Growth Beast On Weakness

Feb 27

Animal Kingdom's Ally: Zoetis And Its Path To 10%+ Returns

Jan 10

Zoetis: High-Quality Compounder With A Reasonable Price After Earnings

Nov 09

Zoetis: Significant CapEx Investments For Long-Term Growth, But A Hold Now

Oct 26

Zoetis Is An Impressive Healthcare Compounder

Sep 26

Earnings and Revenue Growth Forecasts

NYSE:ZTS - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202710,6503,0423,1383,67513
12/31/202610,0332,8082,7923,41617
12/31/20259,4622,6542,3192,73014
3/31/20259,2862,5182,2812,945N/A
12/31/20249,2562,4862,2982,953N/A
9/30/20249,1522,4302,3082,945N/A
6/30/20248,9152,3442,1032,718N/A
3/31/20248,7342,3911,7502,399N/A
12/31/20238,5442,3441,6212,353N/A
9/30/20238,3712,2801,4922,197N/A
6/30/20238,2222,2131,2851,999N/A
3/31/20238,0942,0711,4582,152N/A
12/31/20228,0802,1141,3261,912N/A
9/30/20228,0072,0671,2671,850N/A
6/30/20227,9952,0901,4291,977N/A
3/31/20227,8912,0731,6072,122N/A
12/31/20217,7762,0371,7362,213N/A
9/30/20217,6161,9821,7912,252N/A
6/30/20217,4121,9091,7022,161N/A
3/31/20217,0121,7741,6822,118N/A
12/31/20206,6751,6381,6732,126N/A
9/30/20206,5421,6631,5231,990N/A
6/30/20206,3401,6171,4561,934N/A
3/31/20206,3391,6111,3231,814N/A
12/31/20196,2601,5001,3351,795N/A
9/30/20196,1501,4611,3651,797N/A
6/30/20196,0461,3751,4631,841N/A
3/31/20195,9141,3881,4421,790N/A
12/31/20185,8251,428N/A1,790N/A
9/30/20185,7211,164N/A1,814N/A
6/30/20185,5881,115N/A1,703N/A
3/31/20185,442978N/A1,616N/A
12/31/20175,307864N/A1,346N/A
10/1/20175,124937N/A1,024N/A
7/2/20175,018878N/A824N/A
4/2/20174,957855N/A781N/A
12/31/20164,888821N/A713N/A
10/2/20164,885689N/A705N/A
7/3/20164,858639N/A670N/A
4/3/20164,825378N/A655N/A
12/31/20154,765339N/A664N/A
9/27/20154,811443N/A773N/A
6/28/20154,807420N/A672N/A
3/29/20154,790593N/A709N/A
12/31/20144,785583N/A626N/A
9/28/20144,719562N/A537N/A
6/29/20144,612527N/A548N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ZTS's forecast earnings growth (7.4% per year) is above the savings rate (2.8%).

Earnings vs Market: ZTS's earnings (7.4% per year) are forecast to grow slower than the US market (14.1% per year).

High Growth Earnings: ZTS's earnings are forecast to grow, but not significantly.

Revenue vs Market: ZTS's revenue (5.2% per year) is forecast to grow slower than the US market (8.4% per year).

High Growth Revenue: ZTS's revenue (5.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ZTS's Return on Equity is forecast to be very high in 3 years time (50.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/11 07:45
End of Day Share Price 2025/05/09 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Zoetis Inc. is covered by 42 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
Ishan MajumdarBaptista Research
Douglas TsaoBarclays